United States, New Jersey — Woodland Park, New Jersey

United States, New Jersey is a clinical research site located in Woodland Park, New Jersey, United States 07424.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

United States, New Jersey has participated in 1 clinical trials.

Therapeutic areas: Dry Eye, Keratoconjunctivitis Sicca.

Sponsors: Oyster Point Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, New Jersey?

United States, New Jersey has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, New Jersey conducted?

United States, New Jersey has 1 clinical trials on record. Their work covers Dry Eye, Keratoconjunctivitis Sicca.

Is United States, New Jersey accredited by Crixeo Health?

United States, New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.